Brzosko M - Search Results

1

Ocular circulation in systemic lupus erythematosus.

Modrzejewska M, Ostanek L, Bobrowska-Snarska D, Karczewicz D, Wilk G, Brzosko M, Harris A. Modrzejewska M, et al. Among authors: brzosko m. Med Sci Monit. 2009 Nov;15(11):CR573-8. Med Sci Monit. 2009. PMID: 19865056

2

Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis.

Pawlik A, Ostanek L, Brzosko I, Gawroska-Szklarz B, Brzosko M, Dabrowska-Zamojcin E. Pawlik A, et al. Among authors: brzosko i, brzosko m. Clin Pharmacol Ther. 2002 Sep;72(3):319-25. doi: 10.1067/mcp.2002.126740. Clin Pharmacol Ther. 2002. PMID: 12235453

3

FC gamma RIIa polymorphism in patients with rheumatoid arthritis.

Pawlik A, Ostanek L, Brzosko I, Brzosko M, Fabrycy IF, Florczak M, Szklarz BG. Pawlik A, et al. Among authors: brzosko i, brzosko m. Clin Exp Rheumatol. 2002 Nov-Dec;20(6):841-4. Clin Exp Rheumatol. 2002. PMID: 12508778

4

The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis.

Pawlik A, Ostanek L, Brzosko I, Brzosko M, Masiuk M, Machalinski B, Gawronska-Szklarz B. Pawlik A, et al. Among authors: brzosko i, brzosko m. Arthritis Res Ther. 2003;5(4):R210-3. doi: 10.1186/ar766. Epub 2003 May 14. Arthritis Res Ther. 2003. PMID: 12823856 Free PMC article.

5

Therapy with infliximab decreases the CD4+CD28- T cell compartment in peripheral blood in patients with rheumatoid arthritis.

Pawlik A, Ostanek L, Brzosko I, Brzosko M, Masiuk M, Machalinski B, Szklarz BG. Pawlik A, et al. Among authors: brzosko i, brzosko m. Rheumatol Int. 2004 Nov;24(6):351-4. doi: 10.1007/s00296-003-0374-4. Epub 2003 Sep 23. Rheumatol Int. 2004. PMID: 14504910

6

The influence of N-acetyltransferase 2 polymorphism on rheumatoid arthritis activity.

Pawlik A, Ostanek L, Brzosko I, Brzosko M, Dabrowska-Zamojcin E, Gawronska-Szklarz B. Pawlik A, et al. Among authors: brzosko i, brzosko m. Clin Exp Rheumatol. 2004 Jan-Feb;22(1):99-102. Clin Exp Rheumatol. 2004. PMID: 15005011

7

The urinary excretion of pyridinoline and deoxypyridinoline during rheumatoid arthritis therapy with infliximab.

Ostanek L, Pawlik A, Brzosko I, Brzosko M, Sterna R, Droździk M, Gawrońska-Szklarz B. Ostanek L, et al. Among authors: brzosko i, brzosko m. Clin Rheumatol. 2004 Jun;23(3):214-7. doi: 10.1007/s10067-003-0856-5. Epub 2004 Feb 26. Clin Rheumatol. 2004. PMID: 15168147

8

[Recurrent polychondritis. Presentation of two cases and a review of the literature].

Fliciński J, Brzosko M, Ostanek L, Płońska E, Cyryłowski L. Fliciński J, et al. Among authors: brzosko m. Pol Arch Med Wewn. 2004 Sep;112(3):1093-9. Pol Arch Med Wewn. 2004. PMID: 15727091 Review. Polish.

9

TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis.

Pawlik A, Florczak M, Ostanek L, Brzosko M, Brzosko I, Szklarz BG. Pawlik A, et al. Among authors: brzosko i, brzosko m. Scand J Rheumatol. 2005;34(1):22-6. Scand J Rheumatol. 2005. PMID: 15903021

10

Value of high resistance index - HRI calculated from Doppler spectrum of popliteal arteries in patients with systemic lupus erythematosus (SLE).

Walecka A, Sawicki M, Brzosko M, Ostanek L, Fischer K, Kordowski J. Walecka A, et al. Among authors: brzosko m. Med Sci Monit. 2004 Jun;10 Suppl 3:58-62. Med Sci Monit. 2004. PMID: 16538202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters